Phenicarbazide

CHEMBL1593719 Phase 4 ได้รับการอนุมัติ Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
151.2 g/mol
LogP
0.1
Phase
4

Phenicarbazide is a hydrazine derivative with anticonvulsant and monoamine oxidase inhibitory properties that was studied for potential use in epilepsy management. Its clinical development was largely abandoned due to concerns about toxicity associated with its hydrazine chemical structure.

น้ำหนักโมเลกุล

151.1700 g/mol

LogP

0.10

TPSA

67.20 Ų

Lipinski RO5

ผ่าน

Pharmacokinetics (PK)

Pharmacodynamics (PD)

โครงสร้าง 2 มิติ

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

NC(=O)NNc1ccccc1

InChI

InChI=1S/C7H9N3O/c8-7(11)10-9-6-4-2-1-3-5-6/h1-5,9H,(H3,8,10,11)

Molecular Formula

C7H9N3O

HBD / HBA

3 / 2

พันธะที่หมุนได้

2

อะตอมหนัก

11

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

Phenicarbazide is a hydrazine derivative with anticonvulsant and monoamine oxidase inhibitory properties that was studied for potential use in epilepsy management. Its clinical development was largely abandoned due to concerns about toxicity associated with its hydrazine chemical structure.

Yes, Phenicarbazide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1593719. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 61002. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.